Grown Rogue International (GRUSF) Net Income towards Common Stockholders Growth (3y) (2012 - 2023)
Grown Rogue International (GRUSF) Net Income towards Common Stockholders Growth (3y) (2012 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 14.04% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | -0.23% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.87% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 8.71% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -34.81% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 14.78% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 36.74% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2023 | -293.69% |
| Jul 31, 2023 | 31.17% |
| Apr 30, 2023 | 32.39% |
| Jan 31, 2023 | 37.14% |
| Jan 31, 2022 | 55.50% |
| Jul 31, 2021 | 66.58% |
| Apr 30, 2021 | -24.97% |
| Jan 31, 2021 | -18.14% |
| Aug 31, 2018 | -67.50% |
| May 31, 2018 | 6,628.86% |
| Feb 28, 2018 | -14,454.98% |
| Nov 30, 2017 | 16,691.54% |
| Aug 31, 2017 | -735.58% |
| May 31, 2017 | 99.64% |
| Feb 28, 2017 | 25.99% |
| Aug 31, 2016 | 390.83% |
| May 31, 2016 | 168.05% |
| Feb 29, 2016 | 25.99% |
| Aug 31, 2015 | 544.52% |
| May 31, 2015 | 25.99% |